Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romain Daillère

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Biologie Aujourd'Hui|July 7, 2017
[Gut microbiota and efficacy of cancer therapies]Marie Vétizou, Romain Daillère, Laurence Zitvogel
Medecine Sciences : M/S|December 24, 2016
[The role of intestinal microbiota in the response to anti-tumor therapies]Marie Vétizou, Romain Daillère, Laurence Zitvogel
Nature Reviews. Microbiology|May 23, 2017
Anticancer effects of the microbiome and its productsLaurence Zitvogel, Romain Daillère, María Paula Roberti, et al.
Nature Reviews. Cancer|October 1, 2016
Mouse models in oncoimmunologyLaurence Zitvogel, Jonathan M Pitt, Romain Daillère, et al.
Nature Reviews. Clinical Oncology|April 12, 2018
The gut microbiota influences anticancer immunosurveillance and general healthBertrand Routy, Vancheswaran Gopalakrishnan, Romain Daillère, et al.
Cancer Discovery|August 17, 2021
Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?Lisa Derosa, Bertrand Routy, Antoine Desilets, et al.
Science Translational Medicine|January 23, 2015
Cancer and the gut microbiota: an unexpected linkLaurence Zitvogel, Lorenzo Galluzzi, Sophie Viaud, et al.
Comptes Rendus Biologies|April 11, 2018
The impact of the intestinal microbiota in therapeutic responses against cancerAnne-Gaëlle Goubet, Romain Daillère, Bertrand Routy, et al.
Oncoimmunology|May 7, 2014
Why should we need the gut microbiota to respond to cancer therapies?Sophie Viaud, Romain Daillère, Takahiro Yamazaki, et al.
Aging|March 3, 2021
Oral administration of <i>Akkermansia muciniphila</i> elevates systemic antiaging and anticancer metabolitesClaudia Grajeda-Iglesias, Sylvère Durand, Romain Daillère, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Biologie Aujourd'Hui|July 7, 2017
[Gut microbiota and efficacy of cancer therapies]Marie Vétizou, Romain Daillère, Laurence Zitvogel
Medecine Sciences : M/S|December 24, 2016
[The role of intestinal microbiota in the response to anti-tumor therapies]Marie Vétizou, Romain Daillère, Laurence Zitvogel
Nature Reviews. Microbiology|May 23, 2017
Anticancer effects of the microbiome and its productsLaurence Zitvogel, Romain Daillère, María Paula Roberti, et al.
Nature Reviews. Cancer|October 1, 2016
Mouse models in oncoimmunologyLaurence Zitvogel, Jonathan M Pitt, Romain Daillère, et al.
Nature Reviews. Clinical Oncology|April 12, 2018
The gut microbiota influences anticancer immunosurveillance and general healthBertrand Routy, Vancheswaran Gopalakrishnan, Romain Daillère, et al.
Cancer Discovery|August 17, 2021
Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?Lisa Derosa, Bertrand Routy, Antoine Desilets, et al.
Science Translational Medicine|January 23, 2015
Cancer and the gut microbiota: an unexpected linkLaurence Zitvogel, Lorenzo Galluzzi, Sophie Viaud, et al.
Comptes Rendus Biologies|April 11, 2018
The impact of the intestinal microbiota in therapeutic responses against cancerAnne-Gaëlle Goubet, Romain Daillère, Bertrand Routy, et al.
Oncoimmunology|May 7, 2014
Why should we need the gut microbiota to respond to cancer therapies?Sophie Viaud, Romain Daillère, Takahiro Yamazaki, et al.
Aging|March 3, 2021
Oral administration of <i>Akkermansia muciniphila</i> elevates systemic antiaging and anticancer metabolitesClaudia Grajeda-Iglesias, Sylvère Durand, Romain Daillère, et al.
Pageof 3